Search results for “Herpes virus simplex” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 51 patents, we discovered top 27 key players by total patent application. VIROGIN BIOTECH CANADA LTD., Gen-Probe, Inc., Virogin Biotech (Shanghai) Ltd. are dominant in this area. They take 27.45% of the total patent filing.
VIROGIN BIOTECH CANADA LTD.
Canada
Patent: 6
Gen-Probe, Inc.
California, United States
Patent: 5
Virogin Biotech (Shanghai) Ltd.
China
Patent: 3
Wyeth Holdings LLC
United States
Patent: 2
Gencellmed Inc.
South Korea
Patent: 2
Amgen, Inc.
California, United States
Patent: 1
Nippon Paper Industries Co., Ltd.
Tokyo-to, Japan
Patent: 1
Monsanto Co.
Missouri, United States
Patent: 1
Merz Pharma GmbH & Co. KGaA
Sachsen, Germany
Patent: 1
Century Therapeutics, Inc.
Pennsylvania, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Shenzhen Immvira Pharma Co., Ltd.
Guangdong Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 46 patents applied in the last 5 years. We discover 19 most active companies in this area. The fast-growing VIROGIN BIOTECH CANADA LTD., The Brigham & Women's Hospital, Inc., Univ of Pittsburgh take 32.61% of patent filing during this period.
VIROGIN BIOTECH CANADA LTD.
Canada
Patent: 6
The Brigham & Women's Hospital, Inc.
Massachusetts, United States
Patent: 5
Univ of Pittsburgh
United States
Patent: 4
Virogin Biotech (Shanghai) Ltd.
China
Patent: 3
Xinxiang Medical University
Henan Sheng, China
Patent: 2
Gencellmed Inc.
South Korea
Patent: 2
Century Therapeutics, Inc.
Pennsylvania, United States
Patent: 1
Dongguan HEC Biopharmaceutical R&D Co., Ltd.
Guangdong Sheng, China
Patent: 1
Gen-Probe, Inc.
California, United States
Patent: 1
GW Research Ltd.
Cambridgeshire, United Kingdom
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 46 patents in last 5 years, we discover 17 new entrants. VIROGIN BIOTECH CANADA LTD., The Brigham & Women's Hospital, Inc., Virogin Biotech (Shanghai) Ltd. are the most active new entrants in this area.
VIROGIN BIOTECH CANADA LTD.
Canada
Patent: 6
The Brigham & Women's Hospital, Inc.
Massachusetts, United States
Patent: 5
Virogin Biotech (Shanghai) Ltd.
China
Patent: 3
Xinxiang Medical University
Henan Sheng, China
Patent: 2
Gencellmed Inc.
South Korea
Patent: 2
Century Therapeutics, Inc.
Pennsylvania, United States
Patent: 1
Dongguan HEC Biopharmaceutical R&D Co., Ltd.
Guangdong Sheng, China
Patent: 1
GW Research Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Wuhan Canvest Biotechnology Co., Ltd.
Hubei Sheng, China
Patent: 1
Nanjing Daoda Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 23 patents, we discovered top 4 universities and scientific research institutions by total patent application. Xinxiang Medical University, The University of Chicago, University of Saskatchewan are dominant in this area. They take 56.52% of the total patent filing.
Xinxiang Medical University
Henan Sheng, China
Patent: 2
The University of Chicago
Illinois, United States
Patent: 1
University of Saskatchewan
Saskatchewan, Canada
Patent: 1
Southern Medical University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: